▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3596 by analyst upside · 2026-11-13
CNC
Centene Corporation
Healthcare · Market Cap $35B · P/E 24.1x
ANALYST PRICE TARGET
+7.3%
implied upside to consensus target
Current Price $70.27
Consensus Target $75.39
Bull Target $87.0
Bear Target $62.0
Analysts Covering 18
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
6
Hold
10
Sell
1
52-Week Low $31.63
52-Week High $78.08
YTD Return +68.2%
FUNDAMENTALS
Market Cap $35B
P/E Ratio (TTM) 24.1x
Forward P/E 12.7x
EPS (TTM) $2.91
PEG Ratio 0.83
Dividend Yield N/A
Revenue (TTM) $180.4B
Profit Margin 0.8%
52-WEEK RANGE
52-Week Low $31.63
52-Week High $78.08
Current Price $70.27
Bear Target $62.0
Bull Target $87.0
● Now $70.27 ● Target $75.39
TRADING DATA
Avg Volume 4.8M
YTD Return +68.2%
Analyst Count 18
Consensus Hold
Upside to Target +7.3%
Last Updated 2026-11-13

ANALYST SUMMARY

Centene Corporation (CNC) is currently trading at $70.27 with a Wall Street consensus price target of $75.39, implying potential upside of 7.3% over the next 12 months. 18 analysts currently cover CNC, with a consensus rating of Hold - 39% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $87.0, while the most cautious has a target of $62.0.

CNC operates in the Healthcare sector with a market capitalisation of $35B. The stock is up 68.2% year-to-date and is currently trading near the upper end of its 52-week range of $31.63 – $78.08.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CNC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Truist Securities reit
Buy → Buy 2026-11-02 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-10-30 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-10-29 43% win rate (7 calls)
UBS - Reiterated
Neutral → Neutral 2026-10-28 33% win rate (6 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-10-28 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-28 Building track record
Baird - Reiterated
Neutral → Neutral 2026-10-28 Building track record
Cantor Fitzgerald - Reiterated
Overweight → Overweight 2026-10-28 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
47
out of 100
Coverage depth
22/30
Consensus clarity
23/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →